Abanan, Mary Joy H.
HRN: 22-82-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2023
CEFUROXIME 1.5GM (VIAL)
10/23/2023
10/25/2023
IV
1.5grams
Q8hrs X 4 Doses
S/P Primary CS; Thickly MSAF
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes